FENC
Price
$5.27
Change
+$0.05 (+0.96%)
Updated
Sep 19, 10:00 AM (EDT)
48 days until earnings call
VTGN
Price
$3.02
Change
+$0.04 (+1.34%)
Updated
Sep 19, 11:00 AM (EDT)
Ad is loading...

FENC vs VTGN

Header iconFENC vs VTGN Comparison
Open Charts FENC vs VTGNBanner chart's image
Fennec Pharmaceuticals
Price$5.27
Change+$0.05 (+0.96%)
Volume$200
CapitalizationN/A
VistaGen Therapeutics
Price$3.02
Change+$0.04 (+1.34%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
FENC vs VTGN Comparison Chart
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FENC vs. VTGN commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a StrongSell and VTGN is a Sell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (FENC: $5.21 vs. VTGN: $2.99)
Brand notoriety: FENC and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 132% vs. VTGN: 243%
Market capitalization -- FENC: $142.39M vs. VTGN: $81.03M
FENC [@Biotechnology] is valued at $142.39M. VTGN’s [@Biotechnology] market capitalization is $81.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • FENC’s TA Score: 4 bullish, 3 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FENC is a better buy in the short-term than VTGN.

Price Growth

FENC (@Biotechnology) experienced а -0.89% price change this week, while VTGN (@Biotechnology) price change was -4.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.81%. For the same industry, the average monthly price growth was +7.77%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

FENC is expected to report earnings on Nov 06, 2024.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+7.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($142M) has a higher market cap than VTGN($81M). VTGN YTD gains are higher at: -41.732 vs. FENC (-53.538). FENC has higher annual earnings (EBITDA): 6.58M vs. VTGN (-37.57M). VTGN has more cash in the bank: 108M vs. FENC (43.1M). VTGN has less debt than FENC: VTGN (1.99M) vs FENC (31.8M). FENC has higher revenues than VTGN: FENC (48.9M) vs VTGN (971K).
FENCVTGNFENC / VTGN
Capitalization142M81M175%
EBITDA6.58M-37.57M-18%
Gain YTD-53.538-41.732128%
P/E Ratio74.47N/A-
Revenue48.9M971K5,036%
Total Cash43.1M108M40%
Total Debt31.8M1.99M1,598%
FUNDAMENTALS RATINGS
FENC vs VTGN: Fundamental Ratings
FENC
VTGN
OUTLOOK RATING
1..100
7161
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
79100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
8681
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for FENC (91). This means that VTGN’s stock grew somewhat faster than FENC’s over the last 12 months.

FENC's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as VTGN (100). This means that FENC’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's SMR Rating (97) in the Biotechnology industry is in the same range as FENC (100). This means that VTGN’s stock grew similarly to FENC’s over the last 12 months.

VTGN's Price Growth Rating (81) in the Biotechnology industry is in the same range as FENC (86). This means that VTGN’s stock grew similarly to FENC’s over the last 12 months.

FENC's P/E Growth Rating (95) in the Biotechnology industry is in the same range as VTGN (100). This means that FENC’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FENCVTGN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
FENC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLT15.620.47
+3.14%
Enlight Renewable Energy Ltd
UCBJY88.970.83
+0.94%
UCB S.A.
YPF23.56-0.09
-0.38%
YPF Sociedad Anonima
DGICA15.25-0.08
-0.52%
Donegal Group
CMRX0.86-0.02
-2.21%
Chimerix

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with SCPX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then SCPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-0.89%
SCPX - FENC
39%
Loosely correlated
+2.37%
VTGN - FENC
31%
Poorly correlated
-3.39%
INKT - FENC
28%
Poorly correlated
-0.71%
ZYME - FENC
26%
Poorly correlated
+1.79%
KRRO - FENC
26%
Poorly correlated
-1.82%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.39%
NTLA - VTGN
45%
Loosely correlated
-0.13%
BEAM - VTGN
43%
Loosely correlated
-0.27%
ADPT - VTGN
43%
Loosely correlated
-0.43%
INZY - VTGN
41%
Loosely correlated
-0.17%
RCKT - VTGN
41%
Loosely correlated
-4.40%
More